Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

ClinicalTrials.gov ID: NCT00016393

Public ClinicalTrials.gov record NCT00016393. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) (IND 59699) Administered Every 21 Days in Patients With Hormone Refractory Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BMS-247550 in treating patients who have prostate cancer that has not responded to hormone therapy.

Study identification

NCT ID
NCT00016393
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2001 (Type not available)
Primary completion
Not listed
Completion
Apr 2006 (Actual)
Last update posted
Jun 24, 2013

2001 – 2006

United States locations

U.S. sites
28
U.S. states
12
U.S. cities
22
Facility City State ZIP Site status
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90033-0804 —
University of California Davis Cancer Center Sacramento California 95817 —
CCOP - Atlanta Regional Atlanta Georgia 30342-1701 —
Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) Hines Illinois 60141 —
University of Kansas Medical Center Kansas City Kansas 66160-7390 —
CCOP - Wichita Wichita Kansas 67214-3882 —
Veterans Affairs Medical Center - Wichita Wichita Kansas 67218 —
MBCCOP - LSU Health Sciences Center New Orleans Louisiana 70112 —
Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana 71130-3932 —
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0330 —
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201-1379 —
Veterans Affairs Medical Center - Detroit Detroit Michigan 48201-1932 —
CCOP - Grand Rapids Grand Rapids Michigan 49503 —
Herbert Irving Comprehensive Cancer Center at Columbia University New York New York 10032 —
James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York 14642 —
Oregon Cancer Institute Portland Oregon 97201-3098 —
Veterans Affairs Medical Center - Portland Portland Oregon 97207 —
Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina 29425 —
CCOP - Upstate Carolina Spartanburg South Carolina 29303 —
Danville Radiation Therapy Center Memphis Tennessee 38104 —
Harrington Cancer Center Amarillo Texas 79106 —
Veterans Affairs Medical Center - Amarillo Amarillo Texas 79106 —
Brooke Army Medical Center Fort Sam Houston Texas 78234-6200 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229-3900 —
Veterans Affairs Medical Center - San Antonio (Murphy) San Antonio Texas 78229 —
CCOP - Scott and White Hospital Temple Texas 76508 —
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle Washington 98104 —
Veterans Affairs Medical Center - Seattle Seattle Washington 98108 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00016393, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2013 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00016393 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →